Back to Journals » OncoTargets and Therapy » Volume 9

PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

Total article views   HTML views PDF downloads Totals
40,901 Dovepress* 16,803+ 3,575 20,378
PubMed Central* 24,098 4,378 28,476
Totals 40,901 7,953 48,854
*Since 7 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
16 0 0 0 4 12

View citations on PubMed and Google Scholar